By M&A — Tarsus Pharmaceuticals Acquires Alkeus, Gildeuretinol for Stargardt Disease The Clinical Trial Vanguard
Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. September 5, 2026.